NCT01585220View on ClinicalTrials.gov

Efficacy and Safety Study of Neuramis in Correction of Nasolabial Fold

PHASE3CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

February 9, 2012

Primary Completion Date

August 30, 2012

Study Completion Date

October 30, 2012

Conditions
Nasolabial Fold
Interventions
DEVICE

HA filler

The study device and comparator device will be intradermally injected to each left and right nasolabial fold according to the randomization.

Trial Locations (2)

135-710

Samsung Medical Center, Seoul

463-707

Seoul National University Bundang Hospital, Seongnam

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT01585220 - Efficacy and Safety Study of Neuramis in Correction of Nasolabial Fold | Biotech Hunter | Biotech Hunter